Skip to main content
MDT
NYSE Life Sciences

美敦力Sphere-9导管用于室性心动过速（VT）获得FDA突破性设备指定

feedReported by Reuters
Sentiment info
Positive
Importance info
8
Price
$83.49
Mkt Cap
$106.973B
52W Low
$79.93
52W High
$106.33
Market data snapshot near publication time

summarizeSummary

美敦力宣布，其Sphere-9导管，用于治疗室性心动过速（VT），已获得FDA的突破性设备指定。这一重要的监管地位表明FDA认为该设备可能为危及生命的疾病提供更有效的治疗，并将加快审查过程。对于美敦力来说，该指定减少了产品上市的风险，并表明其心血管产品组合中未来的收入潜力。这一积极的发展与公司最近收购CathWorks以及对新医疗设备更为有利的监管环境相一致，如最近关于加速Medicare付款的报告所示。投资者现在将密切关注进一步的临床试验进展和获得完全FDA批准和商业推出的时间表。

在该公告发布时，MDT的交易价格为$83.49，交易所为NYSE，所属行业为Life Sciences，市值约为$1069.7亿。 52周交易区间为$79.93至$106.33。 这则新闻被评估为积极市场情绪，重要性评分为8/10。 来源：Reuters。

show_chartPrice Chart

Share this article

Copied!

feed MDT - Latest Insights

MDT
Apr 25, 2026, 12:34 PM EDT
Source: Reuters
Importance Score:
8
Medtronic's Sphere-9 Catheter for VT Earns FDA Breakthrough Device Designation
Sentiment: Positive
View Wiseek Article
MDT
Apr 23, 2026, 8:14 AM EDT
Source: Reuters
Importance Score:
8
US to Speed Up Medicare Payments for New Medical Devices, Cutting Reimbursement Wait Times to Two Months
Sentiment: Positive
View Wiseek Article
MDT
Apr 20, 2026, 7:50 AM EDT
Source: Dow Jones Newswires
Importance Score:
7
Medtronic Finalizes CathWorks Acquisition, Bolstering Cardiovascular Leadership
Sentiment: Positive
View Wiseek Article
MDT
Mar 27, 2026, 9:01 AM EDT
Source: Reuters
Importance Score:
7
FDA Clears Medtronic's Stealth Axis™ Surgical System for Cranial, ENT Procedures
Sentiment: Positive
View Wiseek Article
MDT
Mar 24, 2026, 4:43 PM EDT
Source: Wiseek News
Importance Score:
8
Medtronic Cuts FY26 EPS Guidance by Over 2% on MiniMed Flex Charge, Dilution
Sentiment: Negative
View Wiseek Article
MDT
Mar 24, 2026, 4:42 PM EDT
Filing Type: 8-K
Importance Score:
7
Medtronic Lowers FY2026 EPS Guidance by $0.12/Share Due to MiniMed Flex Launch Costs and IPO Dilution
Sentiment: Negative
View Wiseek Article
MDT
Mar 24, 2026, 9:25 AM EDT
Source: dpa-AFX
Importance Score:
7
Medtronic Secures Exclusive Distribution for FDA-Approved ViaVerte System, Bolstering Pain Portfolio
Sentiment: Positive
View Wiseek Article
MDT
Mar 23, 2026, 9:38 AM EDT
Source: dpa-AFX
Importance Score:
7
Medtronic's OmniaSecure Lead First to Win FDA Approval for Advanced Cardiac Pacing
Sentiment: Positive
View Wiseek Article
MDT
Mar 10, 2026, 6:45 AM EDT
Source: Dow Jones Newswires
Importance Score:
7
Medtronic to Acquire Scientia Vascular, Expanding Medical Device Portfolio
Sentiment: Neutral
View Wiseek Article
MDT
Mar 06, 2026, 12:11 PM EST
Source: Reuters
Importance Score:
8
Medtronic's MiniMed Unit Shares Drop 4.8% in Nasdaq Debut, Valued at $5.3 Billion
Sentiment: Negative
View Wiseek Article